Radiopharm Theranostics (RADX) Total Current Liabilities (2024 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Radiopharm Theranostics (RADX) has disclosed Total Current Liabilities for 1 consecutive years, with $14.9 million as the latest value for Q2 2025.

• On a quarterly basis, Total Current Liabilities changed N/A to $14.9 million in Q2 2025 year-over-year; TTM through Jun 2025 was $14.9 million, a N/A change, with the full-year FY2025 number at $14.9 million, changed N/A from a year prior.
• Total Current Liabilities was $14.9 million for Q2 2025 at Radiopharm Theranostics.
• In the past five years, Total Current Liabilities ranged from a high of $14.9 million in Q2 2025 to a low of $14.9 million in Q2 2025.

Peer Comparison